News
Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...
Eli Lilly shares have underperformed the broader market over the past year, but Wall Street analysts remain firmly bullish in ...
The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.
Wegovy and Zepbound - except the weight regain is worse, because of the extreme way in which these medications suppress your ...
Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the ...
Discover how weight loss medications and smart nutrition can silence cravings in Food Noise by Dr. Jack Mosley.
13h
Interesting Engineering on MSNOzempic-style obesity drug bypasses neurons, avoids nausea and vomiting side effectsA new drug that skips neurons and targets support cells cut weight and improved insulin response in lab animals, without ...
Researchers found that brain support cells produce a chemical that suppresses appetite, and they created a modified version ...
This maker of weight-loss drugs saw its share price zoom and then crash. The CEO has been replaced. The incoming boss will ...
In their zeal to “Make America Healthy Again,” Trump administration officials are making statements that some advocacy and ...
Dr. Tim Church predicted recently that GLP-1 agonists, GLP-1 /GIP agonists and similar prescription drugs will soon be as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results